GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Health Sciences Group HESG · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2012

Revenue

$358,434

FY2012FY2012

Net income

−$54,487

FY2012FY2012

Free cash flow

$41,990

FY2012FY2012

Shareholders' equity

$595,868

FY2012FY2012

Income statement

Fiscal years

FY2012
Revenue$358,434
Gross profit$25,228
Operating income−$54,487
Net income−$54,487
Diluted earnings per share-0.03

Balance sheet

At each fiscal year end

FY2012
Total assets$1.0m
Cash and short-term investments$1,376
Total liabilities$435,728
Debt$320,000
Shareholders' equity$595,868
Shares outstanding2m

Cash flow

Fiscal years

FY2012
Cash from operations$41,992
Capital spending−$2
Free cash flow$41,990

Latest quarters

By quarter end

Sept 2006Jun 2006Mar 2006Dec 2005Sept 2005Jun 2005Mar 2005Dec 2004
Revenue$4,943$7,608$20,372$36,391$19,382—$4,369−$4.5m
Gross profit$1,727$2,064$5,349$8,600$10,854—$3,459−$456,000
Operating income−$911,000$1.5m−$2.0m−$1.0m−$2.9m$1.7m−$1.9m−$1.0m
Net income−$950,000−$1.2m−$1.7m$23,014−$2.1m$691,396−$4.2m−$6.6m
Diluted earnings per share-0.02-0.03-0.040.00-0.080.03-0.17-0.46
Cash from operations—————−$1.0m−$1.0m−$1.0m
Total assets$3.7m$3.8m$4.1m$4.2m$5.1m$5.9m$6.6m$4.4m
Cash and short-term investments$1,705$6,593$30,103$21,256$295,237$1.3m$2.1m$240,532
Debt$407,000$365,000$345,000$1.5m$541,923$315,000$400,731$1.0m
Shareholders' equity−$4.7m−$4.5m−$4.4m−$4.9m−$6.1m−$6.4m−$7.1m−$6.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue81.3%-41.8%—
Operating income-80.6%-57.2%—
Net income-78.8%-62.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin16.4%20.2%19.4%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%-90%0%0%1500%1500%150%0%0%0%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.